protagx, a pioneering solution provider in precision data management, showcased its new tools for handling data from Whole Exome Sequencing (WES) and Multiplex Immunofluorescence (IF) at the Precision Medicine Exhibition and Summit (PMES) 2023 event.
With a focus on the medical services sector in the realm of precision medicine, protagx offers granular, rule-based data tagging specifically tailored to healthcare providers. Their platform enables efficient collection, classification, and utilization of genomic files along with their metadata. By optimizing healthcare operations, practitioners can make data-driven decisions and unlock new growth opportunities.
protagx’s participation in PMES2023 reaffirmed their commitment to granularity and data separation in precision data management. It also provided an opportunity to establish new connections and partnerships within the industry.
Leveraging a robust architecture with local fast caching, unprecedented granularity of consented access and ownership rules, and retention policies, protagx’s pipelines ensure a high level of data clearance. This empowers organizations to facilitate new multidimensional learning models and create flawless AI/ML workspaces.
Given the rapid evolution of Next-Generation Sequencing (NGS) and Multiplex IF data in Precision Medicine, achieving data integrity is once again attainable.